Sawyer & Company Inc bought a new position in Walgreens Boots Alliance Inc (NASDAQ:WBA) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 3,255 shares of the pharmacy operator’s stock, valued at approximately $236,000.

Other institutional investors have also recently modified their holdings of the company. Commonwealth Bank of Australia lifted its stake in Walgreens Boots Alliance by 139.5% in the 2nd quarter. Commonwealth Bank of Australia now owns 46,167 shares of the pharmacy operator’s stock worth $3,614,000 after purchasing an additional 26,893 shares in the last quarter. Andra AP fonden lifted its stake in Walgreens Boots Alliance by 6.9% in the 3rd quarter. Andra AP fonden now owns 62,300 shares of the pharmacy operator’s stock worth $4,811,000 after purchasing an additional 4,000 shares in the last quarter. Schwab Charles Investment Management Inc. lifted its stake in Walgreens Boots Alliance by 5.4% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 3,019,739 shares of the pharmacy operator’s stock worth $236,476,000 after purchasing an additional 154,995 shares in the last quarter. Birinyi Associates Inc. lifted its stake in Walgreens Boots Alliance by 9.0% in the 2nd quarter. Birinyi Associates Inc. now owns 9,100 shares of the pharmacy operator’s stock worth $713,000 after purchasing an additional 750 shares in the last quarter. Finally, Legal & General Group Plc lifted its stake in Walgreens Boots Alliance by 5.2% in the 2nd quarter. Legal & General Group Plc now owns 4,550,856 shares of the pharmacy operator’s stock worth $356,368,000 after purchasing an additional 223,186 shares in the last quarter. 61.20% of the stock is owned by institutional investors.

Shares of Walgreens Boots Alliance Inc (WBA) opened at $75.78 on Thursday. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.96 and a quick ratio of 0.47. Walgreens Boots Alliance Inc has a 1 year low of $63.82 and a 1 year high of $88.00. The firm has a market cap of $75,050.00, a PE ratio of 20.93, a P/E/G ratio of 1.29 and a beta of 1.22.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.27 by $0.01. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The company had revenue of $30.74 billion for the quarter, compared to analyst estimates of $30.39 billion. During the same period in the prior year, the company posted $1.10 EPS. The firm’s revenue for the quarter was up 7.9% on a year-over-year basis. equities research analysts predict that Walgreens Boots Alliance Inc will post 5.7 earnings per share for the current fiscal year.

Walgreens Boots Alliance declared that its Board of Directors has approved a share buyback program on Wednesday, October 25th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the pharmacy operator to repurchase shares of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s board of directors believes its shares are undervalued.

Several brokerages have commented on WBA. Needham & Company LLC reiterated a “buy” rating and issued a $88.00 price target (up previously from $86.00) on shares of Walgreens Boots Alliance in a research note on Wednesday, January 10th. BidaskClub upgraded shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Wednesday, January 10th. Loop Capital set a $90.00 price target on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Thursday, October 26th. Robert W. Baird restated an “outperform” rating and set a $80.00 target price (down from $90.00) on shares of Walgreens Boots Alliance in a research report on Thursday, October 19th. They noted that the move was a valuation call. Finally, Citigroup decreased their target price on shares of Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating on the stock in a research report on Thursday, November 2nd. Nine research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $86.20.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total value of $184,324.32. Following the transaction, the director now directly owns 16,415 shares in the company, valued at approximately $1,105,878.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Stefano Pessina bought 98,858 shares of the company’s stock in a transaction on Monday, January 15th. The stock was bought at an average price of $76.07 per share, for a total transaction of $7,520,128.06. The disclosure for this purchase can be found here. Corporate insiders own 14.80% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Sawyer & Company Inc Buys Shares of 3,255 Walgreens Boots Alliance Inc (WBA)” was published by Watch List News and is owned by of Watch List News. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark law. The correct version of this news story can be viewed at https://www.watchlistnews.com/sawyer-company-inc-buys-shares-of-3255-walgreens-boots-alliance-inc-wba/1812021.html.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.